8
Jul
2026

The Government Pharmaceutical Organization (GPO)

Exhibitor at CPHI South East Asia 2026 stand L08
About Us

The Pharmaceutical Organization, a state-owned enterprise under the Thai Ministry of Public Health, was established on August 5, 1966, to manufacture drugs and medical supplies domestically, reducing reliance on imports and strengthening the pharmaceutical industry. It also conducts research on treatments for emerging diseases and educates the public on proper medication use and hygiene to promote overall public health.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Thailand
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Association/Government
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • +6623548857
  • 75/1 Rama 6 Rd., Tungpayathai, Ratchathewi,, Bangkok, Thailand
Show contact info Hide contact info
Event information
CPHI South East Asia 2026
  • 08 Jul 2026 - 10 Jul 2026
  • QSNCC, Bangkok, Thailand
  • Visit us at stand L08

Products Featured at CPHI South East Asia 2026

  • DALAVIR

    Product DALAVIR

    Dolutegravir/Lamivudine/Tenofovir disoproxil fumarate 50/300/300 mg

    Dolutegravir increases the immune cells that help fight infections in the body and decreases the amount of HIV in the blood.

    WHO recommends Dolutegravir as preferred HIV treat...
  • GPO-L-ONE

    Product GPO-L-ONE

    Deferiprone Tablet 500 mg

    Iron Chelating Agent
    For Treatment of iron overload in thalassemia patients
    Oral Iron Chelator for Good Compliance

    High Affinity for iron Binding

    Effective Removal of Excess Iron from the Body

    Provides Significant Ca...
  • TEDAVIR

    Product TEDAVIR

    Dolutegravir/Emtricitabine/Tenofovir Alafenamide Tablets 50/200/25 mg are indicated for use as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 40 kg. In addition to being used for treatment. The product is smal...